Elocon Scalp Lotion

Elocon scalp application is a prescription-only topical corticosteroid lotion containing mometasone furoate 0.1% in an alcohol and propylene glycol-based vehicle. It's designed specifically for the scalp and other hair-bearing areas, where a cream or ointment would be difficult to apply evenly, uncomfortable to wear, and awkward to wash out. It treats inflammatory scalp conditions including scalp psoriasis, scalp seborrhoeic dermatitis, and scalp atopic dermatitis. Like all Elocon formulations, it's classified as a potent topical steroid, is applied once daily, and requires a prescription.

The active ingredient is identical, but the vehicle is completely different. The scalp application uses an alcohol and propylene glycol-based lotion that spreads easily through parted hair, contacts the scalp skin directly, and dries quickly after application, leaving minimal residue on the hair. This makes it far more practical for hair-bearing areas than the cream (which goes sticky and greasy in hair) or the ointment (which is almost impossible to apply evenly through hair and very difficult to wash out). The trade-off is that the alcohol base can sting on application, particularly if the scalp is cracked, broken from scratching, or severely inflamed. The scalp application also carries a specific fire hazard warning because the alcohol base is flammable while the lotion is still wet.

Part the hair to expose the affected area of scalp. Apply a few drops of the lotion directly to the scalp skin (not to the hair) using the applicator nozzle, and spread gently with the fingertips through the affected areas. The lotion should reach the scalp skin, not just the hair shaft; applying it through the hair without making contact with the scalp wastes the dose. Allow the scalp to dry naturally after application, which takes a few minutes. Don't cover the head with a cap, hat, or plastic wrap immediately after applying, as this creates an occlusive environment that significantly increases steroid absorption and side effect risk. Wash hands after applying.

Yes. The alcohol base is flammable while the lotion is still wet on the scalp. The real-world risk in everyday use is low, but it's genuine enough to be listed as a specific product warning. Don't smoke, stand near open flames (candles, gas hobs, bonfires), or use a high-heat hairdryer immediately after applying the lotion. Allow the application to dry fully before using any heat-generating hair appliances. Once the lotion has dried, the flammability risk is gone.

The three main scalp conditions it addresses have overlapping features but different underlying causes. Scalp psoriasis produces thick, silvery-white scales on well-defined red plaques, typically at the hairline, behind the ears, and on the crown; it's intensely itchy and the plaques can extend beyond the hairline onto the forehead and neck. Scalp seborrhoeic dermatitis produces greasy, yellowish scales with redness and itch, particularly in oilier zones of the scalp; it's closely related to a yeast called Malassezia and often waxes and wanes with stress, weather, and skin oiliness. Scalp eczema (atopic dermatitis on the scalp) produces dry, flaky, itchy patches without the thick scaling of psoriasis or the greasy quality of seborrhoeic dermatitis. All three respond to reducing inflammation, which Elocon scalp application does, but each also benefits from condition-specific treatments alongside: antifungal shampoos for seborrhoeic dermatitis, coal tar or salicylic acid shampoos for psoriasis, and emollient-based scalp products for eczema.

Yes. The lotion is suitable for any hair-bearing area where cream or ointment would be impractical, including beard areas, chest, and other body sites with significant hair coverage. The same principle applies: apply to the skin beneath the hair rather than to the hair itself. For clearly defined non-hairy skin patches, the cream or ointment provides more consistent coverage and is generally the better choice.

Once daily for up to 3 to 4 weeks, reviewed at that point. Many patients with scalp psoriasis or seborrhoeic dermatitis use the scalp application during acute flares and then maintain remission with medicated shampoos between flares, rather than using a potent topical steroid continuously. Reducing application frequency as the scalp improves (every other day, then twice weekly) before stopping helps avoid a rebound flare.

Topical steroids themselves don't directly cause hair loss in normal use, and this is one of the most common concerns patients raise about scalp steroids. What the underlying scalp conditions (psoriasis, seborrhoeic dermatitis, eczema) can cause is temporary hair shedding (telogen effluvium) driven by chronic inflammation and repeated scratching. Treating the underlying inflammation with Elocon scalp application typically reduces this shedding. Prolonged daily use of a potent steroid on the scalp can theoretically affect the hair follicle environment over time, but this is uncommon in practice with appropriately limited courses.

Yes, and for scalp psoriasis and seborrhoeic dermatitis particularly, combining the lotion with a medicated shampoo generally gives better results than either alone. Coal tar shampoos, ketoconazole shampoos (Nizoral), ciclopirox olamine, and salicylic acid-based products are commonly used alongside Elocon scalp application. Apply the shampoo at wash time to reduce scale and address the broader condition, then apply the lotion to the dry scalp after washing for the anti-inflammatory effect. Don't apply the lotion immediately before shampooing; the dose will be washed away before it has had time to absorb.

Stinging or burning on application is the most commonly reported effect and relates to the alcohol base. It's more pronounced if the scalp is cracked, broken from scratching, or acutely inflamed, and it usually settles as the scalp heals over the first few applications. Other local effects include skin thinning of the scalp skin with prolonged use, occasional folliculitis (small infected hair follicle spots), and rarely, contact allergy to one of the lotion ingredients. Systemic effects (HPA axis suppression with extensive prolonged use) apply to scalp treatment as to body treatment, though the limited total surface area of most scalp applications keeps systemic exposure relatively low for most patients.

The scalp application carries the same paediatric licence as the other Elocon formulations, from age 2, and can be used in children for scalp psoriasis and eczema under medical supervision. Course length and area treated are kept limited in children. In pregnancy, short-term use on the scalp is generally considered acceptable when clinically needed; the scalp represents a relatively small surface area and systemic absorption is limited. In breastfeeding, the scalp application is generally compatible for short-term use. A GP or dermatologist can advise on individual circumstances.

A scalp showing no improvement after 3 to 4 weeks, or worsening despite treatment, warrants reassessment: the diagnosis may need revisiting, a superinfection may have developed, or a different approach is needed. Signs of bacterial infection on the scalp include increasing pain or tenderness, warmth, swelling, and pus-filled spots. Tinea capitis (scalp ringworm), which steroids actively worsen, presents with patchy hair loss, scaling, and sometimes a ring-like pattern; this is more common in children than adults but shouldn't be missed. Severe or extensive scalp psoriasis that hasn't responded to topical treatment should be reviewed by a GP or dermatologist for consideration of systemic treatments (phototherapy, oral medicines, biologics). Any systemic symptoms (fever, fatigue, joint swelling, unexplained weight loss) alongside a scalp condition always warrant prompt medical review.